SCHEMBL7467485

SCHEMBL7467485

Cc1coc(C=O)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7465109 0.79 TRPA1 (0.30)
SCHEMBL7465107 0.79 TRPA1 (0.30)
SCHEMBL12840925 0.76
SCHEMBL6973127 0.73
SCHEMBL14491143 0.73
SCHEMBL12990363 0.71
SCHEMBL9830085 0.71
SCHEMBL27413585 0.71 TYR (0.30)
SCHEMBL15212591 0.71
SCHEMBL22856694 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112410799-B Method for producing hydrogen 湖南大学 2022-03-29 CN claimed
CN-112410799-A Method for producing hydrogen 湖南大学 2021-02-26 CN claimed
US-12485113-B2 Pharmaceutical use of (e)-3-arylheterocyclylprop-2-enoic acid derivatives MEDCURIUS INC. (CN) 2025-12-02 US disclosed
US-20230285372-A1 Pharmaceutical use of (E)-3-arylheterocyclylprop-2-enoic acid derivatives MEDCURIUS INC. (CN) 2023-09-14 US disclosed
US-20230285372-A1 Pharmaceutical use of (E)-3-arylheterocyclylprop-2-enoic acid derivatives MEDCURIUS INC. (CN) 2023-09-14 US disclosed
US-20230285372-A1 Pharmaceutical use of (E)-3-arylheterocyclylprop-2-enoic acid derivatives MEDCURIUS INC. (CN) 2023-09-14 US disclosed
CN-111556871-B 1H-pyrazolo [4,3-b ] pyridines as PDE1 inhibitors H.隆德贝克有限公司 2023-07-07 CN disclosed
US-20220106327-A1 INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-07 US disclosed
CN-112410799-B Method for producing hydrogen 湖南大学 2022-03-29 CN disclosed
WO-2021259143-A1 PHARMACEUTICAL USE OF (E)-3-ARYLHETEROCYCLYL PROP-2-ENOIC ACID DERIVATIVES 上海长车生物科技有限公司 2021-12-30 WO disclosed
CN-112410799-A Method for producing hydrogen 湖南大学 2021-02-26 CN disclosed
US-10646494-B2 Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases MERCK SHARP & DOHME CORP. (US) 2020-05-12 US disclosed
CN-109311872-A 1H- pyrazolo [4,3-b] pyridine as PDE1 inhibitor H.隆德贝克有限公司 2019-02-05 CN disclosed
WO-2018032468-A1 HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2018-02-22 WO disclosed
EP-0771796-B1 Substituted S-triazines and process for their preparation AGFA GEVAERT (BE) 2002-06-19 EP disclosed
CN-1051546-C Novel 1,1-bis (heteroazolyl) alkane derivatives and their use as neuroprotective agents ASTRA AB (SE) 2000-04-19 CN disclosed
CN-1150426-A Novel 1,1-bis (heteroazolyl) alkane derivatives and their use as neuroprotective agents ASTRA AB (SE) 1997-05-21 CN disclosed
EP-0771796-A1 Substituted S-triazines and process for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-07 EP disclosed